Sigyn Therapeutics, Inc. filed its 10-K on Mar 21, 2022 for the period ending Dec 31, 2021. In this report its auditor, Benjamin & Ko, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.25 USD | +5.00% |
|
-.--% | +10.99% |
Chiffre d''affaires - Rate of surprise
- Stock Market
- Equities
- SIGY Stock
- News SIGN THERPAR
- Sigyn Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt